Skip to Main Content

Paper Details

Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers.
Arch Cancer Biol Ther
2
2020
Author NameAffiliation
Kevin CamphausenNational Cancer Institute, National Institutes of Health
Kevin CamphausenNational Cancer Institute, National Institutes of Health
Uma ShankavaramNational Cancer Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2